Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting267%
active_not_recruiting133%

Recent Activity

3 active trials
Showing 3 of 3
recruiting

Aveir VR Coverage With Evidence Development Post-Approval Study

NCT05336877
recruiting

Aveir VR Real-World Evidence Post-Approval Study

NCT05270499
active_not_recruitingnot_applicable

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

NCT04559945

Clinical Trials (3)

Showing 3 of 3 trials
NCT05336877

Aveir VR Coverage With Evidence Development Post-Approval Study

Recruiting
NCT05270499

Aveir VR Real-World Evidence Post-Approval Study

Recruiting
NCT04559945Not Applicable

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Active Not Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3